May 12, 2025

Tango Therapeutics

Tango Therapeutics Reports First Quarter 2025 Financial ResultsĀ and Provides Business Highlights

May 08, 2025

Synnovation Therapeutics

Synnovation Therapeutics Announces the Appointment of Rafael G. Amado, M.D., to Its Board of Directors

May 07, 2025

Marea Therapeutics

Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress

May 01, 2025

Tango Therapeutics

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

April 28, 2025

Clasp Therapeutics

Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial with a First-in-Class T-Cell Engager Designed to Target Cancer Cells with Absolute Specificity

Load More

Sign up for weekly portfolio news.